Evidence map›Paper›PMID 16414984›Full record

ReviewJournal of virology2006

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors.

Bryan R Cullen

Abstract readReview
In one paragraph

Review in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. Journal of virology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Recent advances on human mpox.New microbes and new infections · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Roles of peptidyl prolyl isomerase Pin1 in viral propagation.Frontiers in cell and developmental biology · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bryan R CullenDepartment of Molecular Genetics and Microbiology, Box 3025, Duke University Medical Center, Durham, NC 27710, USA. culle002@mc.duke.edu

Funding

Effect of APOBEC3G on retroviruses and retrotransposonsR01AI065301 · NIAID · DUKE UNIVERSITY · PI CULLEN, BRYAN R. · 2005 to 2009
$1.7M
Molecular Mechanism of HIV-1 Vif FunctionR01AI057099 · NIAID · DUKE UNIVERSITY · PI CULLEN, BRYAN R. · 2004 to 2007
$1.4M
NIAID NIH HHS AI 057099NIAID NIH HHS AI 065301NIAID NIH HHS R01 AI057099NIAID NIH HHS R01 AI065301
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsGene Products, vifHepatitis B virusHIV-1HIV-2HIV InfectionsHumansImmunity, InnateLeukemia Virus, MurineMultigene FamilyNucleoside DeaminasesRetroviridaeRNA EditingSimian Immunodeficiency VirusSpumavirusvif Gene Products, Human Immunodeficiency VirusGene Products, vifNucleoside Deaminasesvif Gene Products, Human Immunodeficiency Virus

Identifiers

PMID16414984
PMCPMC1346961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.